4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010713
Executive Vice President & CFO gave up 155,907 shares (to pay taxes)
- Executive Vice President & CFO acquired 327,770 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Option exercise | +45,290 | 595,309 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Shares withheld for taxes | −16,373 | $8.76 | $143,427 | 578,936 | D |
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Option exercise | +57,340 | 636,276 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Shares withheld for taxes | −24,374 | $8.76 | $213,516 | 611,902 | D |
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Option exercise | +181,159 | 793,061 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Shares withheld for taxes | −92,663 | $8.76 | $811,728 | 700,398 | D |
| Konidaris Tasos Executive Vice President & CFO | 2025-03-04 | Option exercise | +43,981 | 744,379 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-04 | Shares withheld for taxes | −22,497 | $8.84 | $198,873 | 721,882 | D |
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Option exercise · Restricted Stock Units | −45,290 | 45,290 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Option exercise · Restricted Stock Units | −57,340 | 114,679 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Option exercise · Performance-Based Restricted Stock Units | −181,159 | 0 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Grant or award · Performance-Based Restricted Stock Units | +228,310 | 228,310 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-03 | Grant or award · Restricted Stock Units | +114,155 | 114,154 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2025-03-04 | Option exercise · Restricted Stock Units | −43,981 | 131,945 | D | ||
Loading xslF345X05/wk-form4_1741222400.xml…